Search ( 3936 results )
- article
(Updated on )
Focus: Near-real-time epidemiological surveillance of COVID-19-related hospitalizations in France, 2020–2023: SI-VIC
- article
(Updated on )
Editorial. Information Systems in the Face of the COVID-19 Pandemic: Major Challenges and Lessons Learned
- article
(Updated on )
Description and management measures for cases of invasive Group A streptococcal infections since 2015 and during the 2022–2023 national alert, Auvergne-Rhône-Alpes
Introduction – In response to the resurgence of invasive group A streptococcal infections (IGASIs) in late 2022, healthcare professionals were encouraged to report all hospitalized IGASI...
- article
(Updated on )
The emergence of macrolide resistance in Streptococcus pyogenes or group A beta-hemolytic streptococci.
Streptococcus pyogenes, or group A beta-hemolytic streptococcus (GABHS), is responsible for both localized infections such as sore throats and mild skin infections, as well as severe...
- article
(Updated on )
Susceptibility of Streptococcus pyogenes (SGA) to macrolides and related antibiotics in cases of acute tonsillitis in France, winter 2005–2006
In 2005, the rate of macrolide resistance among GAS was estimated in France to be between 16% and 31%; however, no ad hoc epidemiological study had previously attempted to refine this...
- article
(Updated on )
Reports of invasive nosocomial infections caused by Streptococcus pyogenes in the postoperative or postpartum period in France from August 1, 2001, to December 31, 2003
Streptococcus pyogenes, or group A streptococcus (GAS), is a rare cause of nosocomial infection. In France in 2002, it was isolated in 0.3% of nosocomial bacteremias. The case fatality...
- article
(Updated on )
Attempts to quit smoking in the fourth quarter of 2016 and their connection to “Smoke-Free Month”: initial findings from the 2017 Health Barometer
In October 2016, Santé publique France launched the first edition of the "Mois sans tabac" initiative, inspired by the British Stoptober campaign, with the primary goal of encouraging...
- article
(Updated on )
Influenza Surveillance in France, 2023–2024 Season
Introduction – This article presents a summary of the epidemiological and virological data from the influenza epidemic that occurred in France during the 2023–2024 season. Methods – The...
- article
(Updated on )
Leading causes of death in France in 2022 and recent trends
Introduction – This study describes mortality by cause of death in 2022, comparing its trends with those observed between 2015 and 2019 and in 2020 and 2021. Methods – Using death...
- article
(Updated on )
Mapping of Hepatitis Delta Screening in Metropolitan France from 2016 to 2022 Based on Data from the National Health Data System (SNDS)
Among patients who are carriers of the hepatitis B virus (HBV), 5% are infected with the Delta virus (HDV) and face a particularly high risk of cirrhosis and hepatocellular carcinoma...
